Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular Tolerance”

Showing 20 of 0 results

Not applicableUnknownNCT03832335
What this trial is testing

A New Measurement of Anseikonia Tolerance

Who this might be right for
AniseikoniaAnisometropia and Aniseikonia
Glostrup University Hospital, Copenhagen 31
Not applicableStudy completedNCT03961035
What this trial is testing

Comparative Effectiveness and Tolerance of Subliminal Subthreshold Transscleral Cyclophotocoagulation

Who this might be right for
Glaucoma
Fondation Hôpital Saint-Joseph 40
Post-approval studies (Phase 4)Study completedNCT01448018
What this trial is testing

Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Centre Hospitalier Intercommunal Creteil 45
Early research (Phase 1)Study completedNCT00000668
What this trial is testing

A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01227291
What this trial is testing

SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg

Who this might be right for
GlaucomaOcular Hypertension
Sylentis, S.A. 30
Early research (Phase 1)Study completedNCT00990743
What this trial is testing

Tolerance and Effect on Intraocular Pressure After Administration of SYL040012

Who this might be right for
Ocular HypertensionGlaucoma
Sylentis, S.A. 30
Early research (Phase 1)Study completedNCT00357539
What this trial is testing

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Who this might be right for
Eye Infections, Bacterial
Laboratoires Thea
Large-scale testing (Phase 3)Study completedNCT00328653
What this trial is testing

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)

Who this might be right for
Conjunctivitis, Vernal
Santen SAS 118
Early research (Phase 1)Looking for participantsNCT06263998
What this trial is testing

Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

Who this might be right for
Xerophthalmia
Huons Co., Ltd. 60
Not applicableStudy completedNCT05540496
What this trial is testing

Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema

Who this might be right for
Eczema Eyelid
Cosmetique Active International 41
Not applicableNot Yet RecruitingNCT06459219
What this trial is testing

Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects

Who this might be right for
Allergic RhinitisAllergic Conjunctivitis
Sven Schneider, MD 152
Post-approval studies (Phase 4)Study completedNCT01203540
What this trial is testing

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Who this might be right for
Allergic Conjunctivitis
Laboratoires Thea 21
Not applicableUnknownNCT06172530
What this trial is testing

Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops

Who this might be right for
Dry Eye Syndrome
Hanlim Pharm. Co., Ltd. 2,000
Testing effectiveness (Phase 2)Study completedNCT00326508
What this trial is testing

Combination Daclizumab/Denileukin Diftitox to Treat Uveitis

Who this might be right for
Non-infectious Intermediate and Posterior Uveitis
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)Active Not RecruitingNCT06007391
What this trial is testing

Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1

Who this might be right for
Nicotinamide Adverse Reaction
University Hospital, Angers 25
Not applicableStudy completedNCT07338708
What this trial is testing

Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus

Who this might be right for
CataractKeratoconic Subjects
Azienda Ospedaliera Universitaria Integrata Verona 10
Not applicableStudy completedNCT03172364
What this trial is testing

To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin

Who this might be right for
Skin Care
GlaxoSmithKline 122
Not applicableStudy completedNCT00002034
What this trial is testing

The Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche 100
Not applicableUnknownNCT03725566
What this trial is testing

JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients

Who this might be right for
Macular Degeneration
Beijing Tongren Hospital 24
Not applicableStudy completedNCT01859299
What this trial is testing

Intestinal Bacteria and Ocular Inflammatory Disease

Who this might be right for
Uveitis
National Eye Institute (NEI) 131
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation